Professor, Department of Medicine
University of Western Ontario
Director, Dialysis Services
St. Joseph's Health Care, London, Ontario
Medical Director, London Regional Osteoporosis Program

DEGREES AND DIPLOMAS

B.Sc. in Clinical Biochemistry, awarded July 1968, with first class Honours by the University of London, England

M.B.B.S. with Honours in Pathology, Applied Therapeutics, and a Recommendation in Medicine, awarded November 1971, Middlesex Hospital, affiliated with the University of London, England.

Diploma - M.R.C.P.(UK) awarded November 1974

F.R.C.P.(C) admitted November 1977

L.M.C.C. admitted August 1978

F.R.C.P. (UK) elected June 1993

MEDICAL LICENCE # 30324 (College of Physicians and Surgeons of Ontario)

TRAINING

Nov. 1971 - Jan. 1972 Temporary Lecturer, University of London, England, at the Courtauld Institute of Biochemistry

Feb. 1972 - July 1972 House Physician to Dr. F. Scadding, M.D., F.R.C.P., Middlesex Hospital, London, England

Aug. 1972 - Jan. 1973 House Surgeon to Dr. B. Richards, M.D., F.R.C.S., City Hospital, York, England

Feb. 1973 - Jan. 1974 Senior House Officer to Prof. J.R. Mitchell, F.R.C.P., Department of Medicine, General Hospital, Nottingham, England

Feb. 1974 - July 1974 Senior House Officer to Dr. M. Espir. F.R.C.P. Department of Neurology, General Hospital, Nottingham, England

Aug. 1974 - July 1975 Registrat to Prof. C.E. Dent, F.R.S., PhD., M.D., F.R.C.P., Department of Human Metabolism, University College Hospital, London, England.

Aug 1975 - June 1976 Registrar to Dr. B. I. Hoffbrand, D.M., M.R.C.P., Department of Nephrology, Whittington Hospital, London, England.

July 1976 - June 1977 Clinical Resident, Department of Endocrinology, University Hospital, London, Ontario.

July 1977 - June 1978 Chief Resident, Department of Medicine, University Hospital, London, Ontario.

July 1978 - Jan. 1979 Research Fellow, Section of Endocrinology, University Hospital, London, Ontario.

Jan. 1979 - Jan. 1981 Research Fellow, Department of Nephrology, UCLA School of Medicine and V.A. Wadsworth Medical Center, Los Angeles, California.

MEMBERSHIP IN PROFESSIONAL SOCIETIES

Fellow, Royal College of Physicians (UK)
Fellow, Royal College of Physicians (Canada)
Member, Ontario Medical Association
Member, London and District Academy of Medicine
Member, American Society of Nephrology
Member, American Federation of Clinical Research
Member, American Society of Bone & Mineral Research
Member, Canadian Society of Nephrology
Member, International Society of Clinical Densitometry

UNIVERSITY APPOINTMENTS

Jan 1981 - June 1987 Assistant Professor, Faculty of Medicine, University of Western Ontario, London, Ontario.

July 1987 - June 1992 Associate Professor, Faculty of Medicine, University of Western Ontario, London, Ontario

July 1992 - Present Professor, Faculty of Medicine, University of Western Ontario, London, Ontario

HOSPITAL APPOINTMENTS

Jan. 1981 - Present Geographic Full-Time Medical Staff, Divisions of Nephrology and Endocrinology, St. Joseph's Health Centre, London, Ontario.

Jan. 1981 - Present Director, Osteoporosis Program, St. Joseph's Health Centre, London, Ontario.

July 1987 - 2000 Director, Nephrology and Hemodialysis Service, St. Joseph's Health Centre, London, Ontario.

July 1988 - 1994 Deputy Director, LawsonResearch Institute, St. Joseph's Health Centre, London, Ontario.

July 1988 - June 1990 Chairman, Animal Care Committee, St. Joseph's Health Centre, London, Ontario

July 1990 - Present Chairman, Clinical Research Committee, St. Joseph's Health Centre, London,Ontario

July 1990 - Present Chairman, Clinical Research Division, LawsonResearch Institute, St. Joseph's Health Centre, London, Ontario

NATIONAL APPOINTMENTS

July 1986 - Present Chairman, Research Committee, Osteoporosis Society of Canada

Sept. 1990 - Present Member, Scientific Advisory Council, Osteoporosis Society of Canada.

Nov 1999 - Present Vice-chair, Scientific Advisory Council, Osteoporosis Society of Canada

Sept. 1999 Member, Nominating Committee, American Society of Bone & Mineral Research

Sept. 1999 - Present Member, Professional Practice Committee, American Society for Bone and Mineral Research

June 2000 - Panel Member: Ontario Guidelines for the Prevention and Treatment of Osteoporosis Publications Ontario, Toronto

EDITORIAL BOARDS

Oct 1995 - Jan 1999 National Osteoporosis Foundation, USA

May 1997 - Present Journal of Clinical Densitometry

REVIEWER:

SCIENTIFIC JOURNALS
American Journal of Physiology Bone
Canadian Medical Association Journal
Journal of Bone Mineral Research
Journal of Clinical Densitometry
Journal of Clinical Endocrinology & Metabolism
Osteoporosis International
Journal of Pain Research and Management

GRANTING AGENCIES
Canadian Society of Nephrology
Medical Research Council
Ontario Ministry of Health

Jan. 1989 - 1996 Consultant, Bone Research and Development Program, Allelix Bio Pharmaceutical Inc., Mississauga, Ont.

May 1994 - Present Member, Scientific Advisory Committee on Osteoporosis, Eli-Lilly Canada

May 1995 - Present Member, Medical Advisory Committee, MEDAC, Merck Frosst Canada, for metabolic bone diseases
Member, Organizing Committee for MEDAC annual meeting, Napa, California and Chair, Morning Session, April 1997

Aug 1996 - 1998 Member, Medical Advisory Committee, Searle Canada, for evaluating Slow-release Sodium Flouride in the treatment of osteoporosis

Feb 1997 - 1999 Member, Canadian Consensus Group to assess the validity of radiogrammometric absorption as a quantitative measure of measuring peripheral bone mass and it=s relationship to the risk of developing osteoporosis.

Jan 1998 - Present Member, Canadian Bone Metabolism Board, Procter & Gamble Pharmaceuticals, Canada

July 1998 - Present Member, Steering Committee, Phase I and Phase II clinical trials planning committee for Ostabolin (PTH 1-31 lactam), CromMedica Inc., Canada

Jan 2000 - Present Member, Steering Committee for the PTH and alendronate in combination for the treatment of osteoporosis trial, PaTH, D Blac, D Rosen et al, funded by NIH.

Jan 2000 - Present Member, Steering Committee, Phase III Randomized placebo-controlled trial of PTH(1-84) in the treatment of severe osteoporosis, NPS-Allelix.

COMMITTEES: UNIVERSITY/DEPARTMENT/HOSPITAL

Member, Executive Committee, Skeletal Biology Group, UWO

Member, Organizing Committee, Second Regional Symposium in Metabolic Bone Disease organized by the Skeletal Biology Program, UWO: Chair (April 1997)

Contract Officer, Clinical Research, LawsonResearch Institute

Member, Operations Committee, LawsonResearch Institute

Director, "Special Bone Pathology" Laboratory, SJHC

Member, Dialyzer Re-Use Committee, Div. Of Nephrology, Dept. Of Medicine, SJHC

Member, Research Committee, Dept. Of Medicine, SJHC (July 1994 - June 1999)

Member, Appointments and Promotions Committee, Department of Medicine, University of Western Ontario (July 1999 - June 2002